Go Pro
OTCMKTS:BFNH

BioForce Nanosciences (BFNH) Stock Price, News & Analysis

BioForce Nanosciences logo
$2.91 +0.10 (+3.47%)
As of 11:05 AM Eastern

About BioForce Nanosciences Stock (OTCMKTS:BFNH)

Advanced

Key Stats

Today's Range
$2.83
$2.91
50-Day Range
$1.20
$3.90
52-Week Range
$0.18
$4.20
Volume
1,220 shs
Average Volume
6,178 shs
Market Capitalization
$97.54 million
P/E Ratio
291.04
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioForce Nanosciences, Inc. develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.

The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning. In addition to equipment sales, BioForce Nanosciences offers contract research and custom development services, as well as licensing agreements for its intellectual property. Its technologies have been applied in areas such as drug delivery, tissue engineering, advanced filtration, composite materials and sensor development.

Serving academic institutions, government laboratories and corporate research centers, BioForce Nanosciences supports customers worldwide with training, application development and technical service. By combining instrumentation, service offerings and technology licensing, the company aims to accelerate the translation of nanomaterial innovations into practical solutions for life science, industrial and environmental applications.

AI Generated. May Contain Errors.

BioForce Nanosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

BFNH MarketRank™: 

BioForce Nanosciences scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for BioForce Nanosciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BioForce Nanosciences is 281.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.51.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BioForce Nanosciences is 281.28, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.28.

  • Price to Book Value per Share Ratio

    BioForce Nanosciences has a P/B Ratio of 40.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of BioForce Nanosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    BioForce Nanosciences has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BioForce Nanosciences has recently decreased by 91.70%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    BioForce Nanosciences does not currently pay a dividend.

  • Dividend Growth

    BioForce Nanosciences does not have a long track record of dividend growth.

  • News Sentiment

    BioForce Nanosciences has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for BioForce Nanosciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BioForce Nanosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.54% of the stock of BioForce Nanosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    BioForce Nanosciences has minimal institutional ownership at this time.

  • Read more about BioForce Nanosciences' insider trading history.
Receive BFNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BFNH Stock News Headlines

BioForce Nanosciences Delays Annual 10-K Filing
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel
BioForce Nanosciences Holdings, Inc. (BFNH)
BioForce Nanosciences Holdings Inc (BFNH)
BioForce Nanosciences Holdings Inc.
See More Headlines

BFNH Stock Analysis - Frequently Asked Questions

BioForce Nanosciences' stock was trading at $0.5780 on January 1st, 2026. Since then, BFNH stock has increased by 386.2% and is now trading at $2.81.

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) announced its earnings results on Monday, August, 10th. The company reported $0.01 earnings per share (EPS) for the quarter.

Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioForce Nanosciences investors own include Charlotte's Web (CWBHF).

Company Calendar

Last Earnings
8/10/2026
Today
8/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:BFNH
CIK
1310488
Employees
2
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
$0.01
Trailing P/E Ratio
291.04
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.29 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-84.67%
Return on Assets
-16.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
25.41
Quick Ratio
25.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.07 per share
Price / Book
41.54

Miscellaneous

Outstanding Shares
33,549,000
Free Float
20,284,000
Market Cap
$97.54 million
Optionable
Not Optionable
Beta
-0.52

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:BFNH) was last updated on 8/28/2026 by MarketBeat.com Staff.
From Our Partners